Clinical Trial Update: Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

View source ↗

Summary

This trial investigates the causes and modifiable risk factors for covert brain infarctions (silent strokes) to improve understanding of stroke prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Lacunar Stroke
• Stroke

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Silent Stroke, Silent Cerebral Infarct | Status: RECRUITING